Peyronnet, Alexia
Le Barbier, Mélina
Morel, Pauline
Naud, Jérôme
Menard, Céline
Caudeville, Julien
Article History
Received: 9 August 2024
Accepted: 22 July 2025
First Online: 30 September 2025
Declarations
:
: The study whose results are submitted for publication is a survey of stakeholders (health professionals, scientific experts, patient associations, etc.) to help us define our new epidemiological surveillance strategy for endocrine disruptors. It is therefore an opinion survey. No health data relating to respondents or their patients or members was collected. In view of the study’s purpose and the way in which it was implemented, this study is not research involving the human person within the meaning of French legislation (article L. 1121-1 of the Public Health Code), nor within the meaning of the WMA’s Declaration of Helsinki, and did not require the prior opinion of an ethics committee. However, informed consent was obtained after being informed of the conditions under which their data would be processed.
: Not applicable.
: The authors declare no competing interests.